- A new drug for renal cell carcinoma slowed the growth of advanced kidney cancer in patients who became resistant to the first-line therapies that had previously kept it in check, according to results from a clinical trial led by Dana-Farber Cancer Institute.
- Dana-Farber scientists and colleagues use genome- and epigenome-editing tools to pinpoint disease-causing variants.
Tags: BasicResearch, Genomics
- Almost one-third of families whose children were being treated for cancer faced food, housing or energy insecurity and one-quarter lost more than 40 percent of household income, according to a new study from Dana-Farber/Boston Children’s Cancer and Blood Disorders Center published in Pediatric Blood & Cancer.
Tags: ChildhoodCancer, CopingWithCancer
- In the first ever randomized trial in the United States, researchers led by Dr. Wendy Chen will test whether aspirin helps women with breast cancer avoid recurrence and live longer.
- Researchers from Dana-Farber/Boston Children's Cancer and Blood Disorders Center, using CRISPR-based gene editing techniques, have found that changes to a small stretch of DNA may circumvent the genetic defect behind sickle cell disease (SCD), according to a study published in the journal Nature.
Tags: Genomics, Genetics
- Dana-Farber Cancer Institute has named Michael Reney its Chief Financial Officer (CFO), where he will be responsible for all financial operations including accounts payable, financial planning and reporting, payroll, capital asset management, tax and general and patient accounting.
- Tari King, MD, has been named Chief of Breast Surgery at Dana-Farber/Brigham and Women's Cancer Center where she will oversee breast surgery and continue to build DF/BWCC's integrated clinical model for treating breast cancer.
- In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute report.
- The National Committee for Quality Assurance (NCQA) has recognized four Dana-Farber Community Cancer Care sites in Massachusetts for quality of their patient care services.
- Regular consumption of caffeinated coffee may help prevent the return of colon cancer
after treatment and improve the chances of a cure, according to a new, large
study from researchers at Dana-Farber Cancer Institute.
Showing 11-20 of 633 items